scholarly journals Effect of Low Dietary Vitamin D Fed Prior to and During Pregnancy and Lactation on Maternal Bone Mineral Density, Structure and Strength in C57BL/6 Mice

Author(s):  
Christopher R Villa ◽  
Sandra M Sacco ◽  
Jianmin Chen ◽  
Amel Taibi ◽  
Elena M Comelli ◽  
...  

ABSTRACT Several studies have shown that diets containing lower vitamin D than in the AIN-93G diet do not compromise bone structure, bone mineral density (BMD) and/or bone strength in male and female mice. This study determined if a diet containing low vitamin D from pre-pregnancy through the end of lactation maintained these bone outcomes to a similar extent as a high vitamin D diet. Mice were fed an AIN-93G diet with 25 (LD diet) or 5000 (HD diet) IU vitamin D/kg diet from pre-mating through lactation (n = 15/group). Of the major structure outcomes, only cortical area fraction of the distal femur was lower (P < 0.05) with LD diet. Lumbar vertebra BMD was lower (P < 0.05) with LD while distal femur BMD and bone strength at three sites did not differ. Dams fed a LD diet pre-mating through the end of lactation had largely similar bone outcomes to dams fed a HD diet.

Bone ◽  
2006 ◽  
Vol 39 (6) ◽  
pp. 1343-1351 ◽  
Author(s):  
Karl Michaëlsson ◽  
Alicja Wolk ◽  
Annica Jacobsson ◽  
Andreas Kindmark ◽  
Elin Grundberg ◽  
...  

Author(s):  
Anna Casteràs ◽  
Lídia Darder ◽  
Carles Zafon ◽  
Juan Antonio Hueto ◽  
Margarita Alberola ◽  
...  

Summary Skeletal manifestations of primary hyperparathyroidism (pHPT) include brown tumors (BT), which are osteoclastic focal lesions often localized in the jaws. Brown tumors are a rare manifestation of pHTP in Europe and USA; however, they are frequent in developing countries, probably related to vitamin D deficiency and longer duration and severity of disease. In the majority of cases, the removal of the parathyroid adenoma is enough for the bone to remineralize, but other cases require surgery. Hyperparathyroidism in MEN1 develops early, and is multiglandular and the timing of surgery remains questionable. To our knowledge, there are no reports of BT in MEN 1 patients. We present a 29-year-old woman with MEN 1 who developed a brown tumor of the jaw 24 months after getting pregnant, while breastfeeding. Serum corrected calcium remained under 2.7 during gestation, and at that point reached a maximum of 2.82 mmol/L. Concomitant PTH was 196 pg/mL, vitamin D 13.7 ng/mL and alkaline phosphatase 150 IU/L. Bone mineral density showed osteopenia on spine and femoral neck (both T-scores = −1.6). Total parathyroidectomy was performed within two weeks, with a failed glandular graft autotransplantation, leading to permanent hypoparathyroidism. Two months after removal of parathyroid glands, the jaw tumor did not shrink; thus, finally it was successfully excised. We hypothesize that higher vitamin D and mineral requirements during maternity may have triggered an accelerated bone resorption followed by appearance of the jaw BT. We suggest to treat pHPT before planning a pregnancy in MEN1 women or otherwise supplement with vitamin D, although this approach may precipitate severe hypercalcemia. Learning points: Brown tumors of the jaw can develop in MEN 1 patients with primary hyperparathyroidism at a young age (less than 30 years). Pregnancy and lactation might trigger brown tumors by increasing mineral and vitamin D requirements. Early parathyroidectomy is advisable in MEN 1 patients with primary hyperparathyroidism, at least before planning a pregnancy. Standard bone mineral density does not correlate with the risk of appearance of a brown tumor. Removal of parathyroid glands does not always lead to the shrinkage of the brown tumor, and surgical excision may be necessary.


2000 ◽  
Vol 33 (3) ◽  
pp. 289-297 ◽  
Author(s):  
Mats Stenström ◽  
Birger Olander ◽  
Daisy Lehto-Axtelius ◽  
Jan Erik Madsen ◽  
Lars Nordsletten ◽  
...  

Endocrinology ◽  
2007 ◽  
Vol 148 (9) ◽  
pp. 4466-4474 ◽  
Author(s):  
Sara Johnston ◽  
Sharon Andrews ◽  
Victor Shen ◽  
Felicia Cosman ◽  
Robert Lindsay ◽  
...  

A cyclic PTH regimen is as effective as a daily regimen on bone density gain in humans and in improving bone quality in mice. Our previous murine study evaluated the effects of a cyclic PTH regimen in the absence of a bisphosphonate, whereas our human study addressed the effects of a cyclic PTH regimen in the presence of ongoing alendronate (ALN) treatment. Accordingly, the current study examined the effects of cyclic or daily PTH regimens in combination with ALN on bone quality and bone density in mice. Twenty-week-old, female C57BL/6J mice were treated with the following sc injections (n = 10): 1) vehicle for 5 d/wk (control); 2) ALN (20 μg/kg·d) 3 d/wk (ALN); 3) human PTH(1–34) (40 μg/kg·d) 5 d/wk (daily PTH); 4) daily PTH in addition to ALN (daily PTH plus ALN); 5) PTH 5 d/wk and vehicle 5 d/wk alternating weekly (cyclic PTH); 6) cyclic PTH in addition to ALN (cyclic PTH plus ALN); and 7) PTH and ALN alternating weekly (alt PTH and ALN). Bone mineral density was measured weekly by dual-energy x-ray absorptiometry, and at 7 wk, bone markers, bone structure, and bone strength were evaluated by biochemical assays, peripheral quantitative computed tomography and mechanical testing, respectively. At 7 wk, all treatments significantly increased femoral and vertebral bone mineral density. ALN slightly decreased endosteal circumference, whereas PTH increased periosteal circumference, resulting in significant increases in femoral cortical thickness in all groups. PTH and ALN enhanced bone strength synergistically in the lumbar vertebrae and additively in the femur. Combined therapy, however, had no effects on bone markers. The results show that combinations of ALN and PTH, in both daily and cyclic regimens, produce more beneficial effects than treatment with either agent alone, suggesting that the mechanisms of actions of ALN and PTH on bone quality may be complementary.


2017 ◽  
Author(s):  
Taryn Smith ◽  
Laura Tripkovic ◽  
Camilla Damsgaard ◽  
Christian Molgaard ◽  
Aine Hennessy ◽  
...  

2019 ◽  
Author(s):  
Elzbieta Jakubowska-Pietkiewicz ◽  
Maciej Porczynski ◽  
Ewa Rychlowska ◽  
Paulina Albinska ◽  
Elzbieta Wozniak ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document